Physician profile
Susan D Merry
NPI 1447818414
$1,842.12
in general payments reported to CMS, 2019-2025
11 companies · $639 in 2025
The $639 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $250 · 2022: $250 · 2023: $207 · 2024: $497 · 2025: $639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,342.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $494.78 | 2024-2025 | Epclusa, Livdelzi |
| Abbott Laboratories | $260.92 | 2024-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $129.73 | 2024 | Dexcom G7 Gss (161) |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2022 | |
| Abbvie INC. | $125.00 | 2021 | |
| Genentech USA, INC. | $125.00 | 2022 | |
| Ardelyx, INC. | $125.00 | 2025 | Ibsrela |
| Alexion Pharmaceuticals, INC. | $125.00 | 2023 | Ultomiris |
| Kyowa Kirin, INC. | $125.00 | 2025 | |
| Glaxosmithkline, LLC. | $124.76 | 2021 | |
| Inspire Medical Systems, INC. | $81.93 | 2023 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Merry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.